Michael Jacobsen

Director of Finance/CFO bei OMEROS CORPORATION

Vermögen: 42 840 $ am 30.04.2024

65 Jahre

Health Technology

Consumer Services

Aktive Positionen von Michael Jacobsen

Unternehmen	Position	Beginn	Ende
OMEROS CORPORATION	Comptroller/Controller/Auditor	01.10.2013	-
	Director of Finance/CFO	01.08.2013	-
	Treasurer	01.10.2013	-

Unternehmen	Position	Beginn	Ende
SAREPTA THERAPEUTICS, INC.	Comptroller/Controller/Auditor	08.09.2011	-
	Director of Finance/CFO	09.09.2011	15.11.2011
	Corporate Officer/Principal	08.09.2011	08.09.2011
	Corporate Secretary	07.09.2011	22.04.2013
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Chief Operating Officer	01.04.2007	01.08.2011
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Comptroller/Controller/Auditor	-	-
	Director of Finance/CFO	-	-

Idaho State University

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Comptroller/Controller/Auditor	3
Director of Finance/CFO	3
Corporate Officer/Principal	1

Sektoral

Health Technology	5
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
SAREPTA THERAPEUTICS, INC.	Health Technology
OMEROS CORPORATION	Health Technology

Private Unternehmen	2
ICOS Corp. ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA.	Health Technology
ZymoGenetics, Inc. ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.	Health Technology

Private Unternehmen

Health Technology